Efficacy Of Loralatinib In Combination With Alectinib In Patients With Anaplastic Kinase-Positive Small Cell Lung Cancer With Moderate Lung Disease: A Case Report. Clinical and Medical Case Reports 2022, 2 (01), 34-37.